its actions through the natriuretic peptide ␤-receptor tivity (DNP-LI) was reported to be present in human plasma (NPR-B) , which is also linked to particulate guanylyl and atrial myocardium and to be elevated in human congestive cyclase and cGMP generation [7] . Although this family heart failure. Although previously named DNP, it remains unof peptides now consists of three known peptides, the known if DNP is natriuretic or if is it present in canine plasma, discovery of additional genes encoding putative guanylyl urine, and atrial myocardium.
Method. Studies were performed in vivo in anesthetized cyclases has raised the question about the possible exisdogs (N ϭ 6) using intravenous infusion of synthetic DNP tence of numerous ligands for these receptors yet to be at 10 and 50 ng/kg/min. Employing a sensitive and specific discovered in mammal species [8] . Recently, additional radioimmunoassay for DNP, the presence of DNP-like peptide natriuretic peptides have been isolated and characterwas assessed in the canine plasma and urine before, during, ized, particularly from the venom of the snakes Dendroand following the administration of exogenous synthetic DNP. Additionally, we performed immunohistochemical studies usaspis angusticeps, Micrurus corallinus, and Bothrops jaraing the indirect immunoperoxidase method with polyclonal raca [9] [10] [11] . The physiological role of these peptides, as DNP antiserum in normal atrial myocardium (N ϭ 10). Atrial well as their presence in other species, remains unclear.
concentrations of DNP-LI were also assessed.
One of these newly characterized peptides possessing
Results. We report that DNP is markedly natriuretic and a structural similarity to the natriuretic peptide family, diuretic, which, like ANP and BNP, is associated with the inwhich was isolated from the venom of Dendroaspis ancrease in urinary and plasma cGMP. DNP-like peptide is also detected in canine plasma, urine, and atrial myocardium.
gusticeps, or green Mamba snake [9] , is a 38-amino acid
Conclusion. These studies establish that DNP is a potent peptide containing a 17-amino acid disulfide ring strucnatriuretic and diuretic peptide with tubular actions linked to ture with a 15-residue C terminal extension (Fig. 1 ). This cGMP and that DNP may play a physiological role in the peptide potently vasorelaxes isolated rodent aorta [9] regulation of sodium excretion.
and canine coronary arteries with comparable potency to ANP (abstract; Wennberg and Burnett, J Am Coll Cardiol 29:305A, 1997). Additionally, this peptide augInvestigations have established the existence of a famments the formation of cGMP in aortic endothelial and ily of structurally similar but genetically distinct natrismooth muscle cells and displaces ANP binding from uretic peptides that consist of atrial natriuretic peptide the natriuretic peptide receptors [9] . Most recently, we (ANP) and brain natriuretic peptide (BNP) of myocarhave reported that Dendroaspis natriuretic peptide dial cell origin, and C-type natriuretic peptide (CNP) of (DNP)-like immunoreactivity (DNP-LI) is present in huendothelial cell origin [1, 2] . ANP and BNP bind to the man plasma and atrial myocardium and is elevated in the plasma of humans with congestive heart failure [12] . We also determined that DNP levels in normal human that DNP plasma levels averaged 37 pg/ml with a range from 3 to 200 pg/ml.
were anesthetized with pentobarbital sodium given intravenously (30 mg/kg). Supplemental nonhypotensive doses of pentobarbital sodium were given as needed during the experiment. After tracheal intubation, dogs were mechanically ventilated (Harvard respirator; Harvard Apparatus, Millis, MA, USA) with 4 liter/min of supplemental oxygen. Left lateral flank incisions were made, and the left kidney was exposed via a retroperitoneal approach. The ureter was cannulated with polyethylene catheters (PE-200) for a timed urine collection, and a calibrated noncannulating electromagnetic flow probe was placed carefully around the left renal artery and connected to a flowmeter (model FM 5010, Carolina Medical Electronics, King, NC, USA) for continuous monitoring of renal blood flow (RBF). Finally, the right femoral vein was cannulated with two polyethylene catheters (PE-240), one for infusion of inulin and the other for the infusion of DNP (DNP 1-38; Phoenix Pharmaceuticals, Inc., Mountain View, CA, USA). The right femoral artery was cannulated with a polyethylene catheter (PE-240) for direct arterial blood pressure measurement and arterial blood sampling.
After completion of the surgical preparation, a priming dose of inulin (ICN Biomedicals, Cleveland, OH, followed by a constant infusion of 1 ml/min to achieve a steady-state plasma inulin concentration between 40 and 60 mg/dl. The dogs were placed in dorsal suspension and allowed to equilibrate for 60 minutes without interAlthough this peptide, based on its structural similarity vention. Body temperature was maintained by external to ANP, BNP, and CNP, was named DNP, it remains warming (infrared heating lamp). unknown if DNP is natriuretic. Indeed, the renal actions
After an equilibration period of 60 minutes, a 30-of DNP are undefined. minute baseline clearance (baseline) was performed. This Based on the structural similarity to the other natriwas followed by a 15-minute lead-in period, during which uretic peptides and the report that DNP activates cGMP DNP infusion at 10 ng/kg/min was begun intravenously, in vitro, we hypothesized that DNP is a natriuretic and after which the second 30-minute clearance (DNP-10) diuretic peptide. We therefore investigated the renal acperiod was performed. After the second clearance petions of synthetic DNP in vivo in normal anesthetized riod, the intravenous infusion of DNP was changed to dogs. We also determined whether or not DNP-LI is 50 ng/kg/min. After a 15-minute lead-in period with this present in canine plasma, urine, and atrial myocardium.
dose of DNP, a 30-minute clearance (DNP-50) was performed. At the end of the third clearance, the DNP METHODS infusion was stopped and a 150-minute washout period followed with a 30-minute recovery clearance (recovery). Studies were performed in six male mongrel dogs weighing between 20 and 25 kg. Dogs were maintained Analytical methods on a normal-sodium diet with standard dog chow (Lab Canine Diet 5006; Purina Mills, St. Louis, MO, USA)
Plasma for electrolyte and inulin measurements was obtained from blood collected in heparinized tubes. with free access to tap water. All studies conformed to the guidelines of the American Physiological Society and Plasma and urine electrolytes including lithium were measured by flame-emission spectrophotometer (IL943, were approved by the Mayo Clinic Animal Care and Use Committee.
Flame Photometer; Instrumentation Laboratory, Lexington, MA, USA). Plasma and urine inulin concentraOn the evening before the experiment, 300 mg of lithium carbonate were administered orally for the astions were measured by the anthrone method, and the glomerular filtration rate (GFR) was measured by the sessment of renal tubular function, and dogs were fasted overnight. On the day of the acute experiment, all dogs clearance of inulin. The lithium clearance technique was employed to estimate the proximal and distal fractional employing the same sensitive and specific radioimmunoassay. reabsorption of sodium. Proximal fractional reabsorption was calculated by the following formula: [1 Ϫ (lith- Immunohistochemical methods ium clearance/GFR)] ϫ 100. Distal fractional reabsorption of sodium was calculated by this formula: [(lithium Sections for immunohistochemical staining were taken from atrial free walls from 10 normal dogs not exposed clearance Ϫ sodium clearance)/lithium clearance] ϫ 100.
Plasma and urinary cGMP were measured by radioimto exogenous DNP. Immunohistochemical studies were performed by the indirect immunoperoxidase method as munoassay using the method of Steiner, Parker, and Kipnis [13] . Urine for cGMP measurement was heated described previously [14] . Tissues were immediately fixed with 10% buffered formalin and were embedded in parto 90ЊC before storage at Ϫ20ЊC to inhibit degradative enzymatic activity.
affin, and sections 6 m thick were cut and mounted on salinized glass slides. The sections were deparaffinized Plasma and urinary DNP-LI was determined using a specific and sensitive radioimmunoassay for DNP before, with graded concentrations of xylene and were hydrated with ethanol. To block the activity of endogenous peroxiduring, and following the DNP administration. Blood was collected in chilled tubes containing ethylenedidase, the slides were incubated with 0.6% hydrogen peroxide in methanol for 20 minutes at room temperature. aminetetraacetic acid (EDTA) and immediately placed on ice. After centrifugation at 2500 r.p.m. at 4ЊC for 10
After being washed, sections were incubated in 5% normal goat serum (Dako, Carpinteria, CA, USA) for 10 minutes, the plasma was decanted and stored at Ϫ20ЊC until analyzed. Plasma (1 ml) was extracted on C-8 Bond minutes at room temperature to reduce nonspecific background staining and were then incubated with polyclonal Elut cartridges, which were washed with methanol and distilled water. DNP was eluted with 95% methanol conrabbit anti-DNP (Phoenix Pharmaceuticals) at a dilution of 1:500 (in normal goat serum) in humidified chambers taining 1% trifluoroacetic acid (TFA). Concentrated elutes were then assayed with a specific and sensitive for 18 hours at room temperature. All slides were incuradioimmunoassay for DNP (Phoenix Pharmaceuticals).
bated for 30 minutes with the second antibody-horseradUrinary DNP-LI was measured directly by this radioimish peroxidase conjugate (BioSource, Camarillo, CA, munoassay without extraction. Samples and standards USA). The reaction was visualized by incubating the were incubated with rabbit anti-DNP at 4ЊC for 18 hours.
sections with a solution of 3Ј-amino-9Ј-ethylcarbazole 125 I-labeled DNP (100 l) was added and incubated for (Sigma, St. Louis, MO, USA) in dimethylformamide and another 18 hours at 4ЊC. Free and bound fractions were sodium acetate. The sections were counterstained with then separated by the addition of a second antibody/ hematoxylin and were coverslipped and reviewed with normal rabbit serum solution and were centrifuged. Raan Olympus microscope. Control sections were stained dioactivity of the bound fraction was measured with a ␥ with 1% nonimmune goat serum. Specificity of immunocounter. The minimal detectable level for this assay was staining was confirmed by adsorption testing. 0.5 pg per tube, and the IC 50 of the standard curve was Statistical analysis 29.0 pg. Recovery was 83.0 Ϯ 1.8%, and the intra-assay coefficient of variation (CV) was 10.0 Ϯ 1.8% and inResults of quantitative studies are expressed as mean Ϯ terassay CV was 12.0 Ϯ 1.5%. There was no cross-reacse. Statistical comparisons were performed using retivity between the DNP assay and the ANP, BNP, or peated-measures analysis of variance, followed by the CNP assays. We challenged the DNP radioimmunoassay post hoc Bonferroni test. Statistical significance was acwith increasing concentrations of ANP, BNP, and CNP cepted for a P value of less than 0.05. over a range from 0.5 to 500 pg while also challenging the ANP, BNP, and CNP assay with increasing concen-RESULTS trations of DNP over a range from 0.5 to 500 pg. We Plasma DNP and urinary DNP excretion are shown detected no cross-reactivity between the ANP, BNP, in Figure 2 . Employing the specific and sensitive radioim-CNP, and DNP assays. The second methodology, which munoassay, plasma and urinary DNP-LI were detectable was used to test the specificity of the radioimmunoassay prior to infusion of exogenous DNP. Both plasma and for DNP, was immunoblotting. Immunoblotting was perurinary DNP excretion increased during DNP infusion formed employing antibodies to DNP using synthetic and decreased during the recovery period. ANP, BNP, CNP, and DNP at the concentrations of 100, Urinary sodium excretion (U Na V), urine flow (UV), 10, 1, and 0.1 ng, with no cross-reactive staining for ANP, plasma cGMP, and urinary cGMP excretion (U cGMP V) in BNP, or CNP. Positive and dose-dependent immunoresponse to exogenous DNP are illustrated in Figure 3 . staining was noted with the DNP antibody at concentraLow-dose DNP (10 ng/kg/min) increased U Na V in associtions of DNP at 100, 10, and 1 ng. ation with increases in plasma cGMP and U cGMP V. HighAtrial tissue concentration of DNP-LI was determined in the 10 normal dogs not exposed to DNP infusion dose DNP (50 ng/kg/min) further increased U Na V with a significant increase in UV. These natriuretic and diuretic properties in normal dogs and that DNP-LI is present responses to high-dose DNP (DNP-50 clearance) were in canine plasma, urine, and atrial myocardium. DNPalso associated with increases in plasma cGMP and mediated natriuresis and diuresis were associated with U cGMP V compared with baseline and with the previous parallel increases in plasma cGMP and urinary cGMP clearance (DNP-10 clearance). Following DNP infusion, excretion independent of increases in plasma ANP, BNP, U Na V and UV decreased to the baseline values. These or CNP. Finally, the excretory responses to exogenous decreases were accompanied by decreases in plasma DNP administration were associated with decreases in cGMP and U cGMP V.
distal tubular reabsorption of sodium and arterial pres- Table 1 reports the mean arterial pressure (MAP) and sure in the absence of alterations in GFR or RBF. renal function effects of exogenous DNP. Low-dose DNP Similar to the renal responses to ANP and BNP [15, increased fractional sodium excretion (FE Na ) and de-16] , DNP increased urinary cGMP excretion and decreased distal fractional reabsorption of sodium (DFR Na ).
creased distal tubular reabsorption of sodium. These ob-MAP, GFR, and RBF were unchanged. High-dose DNP servations support the conclusion that DNP may function decreased MAP in association with a further increase in through the NPR-A receptor, which is linked to particu-FE Na and decrease in DFR Na without changes in GFR or late guanylyl cyclase and cGMP generation and is also RBF. During the recovery period, MAP returned to near highly expressed in inner medullary collecting duct cells baseline levels with a decrease in RBF. GFR remained [15] . Such a conclusion is also supported by the report unchanged during the experiment, whereas DFR Na inthat DNP displaces ANP binding in vascular smooth creased to baseline levels during recovery period. Proximuscle cells [9] . We cannot, however, exclude the exismal fractional reabsorption of sodium tended to decrease tence of a new, yet to be identified natriuretic peptide during DNP administration (PFR Na at baseline, 63 Ϯ 6; receptor. In addition, the lack of increase in plasma ANP, low-dose DNP, 58 Ϯ 7; high-dose DNP, 58 Ϯ 4; recovery, BNP, and CNP in this study during DNP administration 72 Ϯ 6%) but did not reach a significant level. Plasma also suggests that the renal actions of DNP are direct ANP, BNP, or CNP did not increase during or after and not mediated by the other natriuretic peptides. In DNP administration (Table 2) .
Atrial myocardial presence of DNP immunoreactivity response to high-dose DNP, MAP decreased and rewas determined by measurement of tissue DNP concenturned to near baseline following discontinuation of tration in normal dogs not exposed to exogenous DNP DNP administration. Such hypotensive action is shared administration. Atrial tissue concentrations of DNP were by the other natriuretic peptides, which is secondary to detectable at a concentration of 1950 Ϯ 197 pg/g of wet decreases in both cardiac preload and afterload [17] [18] [19] . tissue. DNP-LI was also present in atrial myocardium
In this study, we cannot exclude that DNP may also of these dogs using immunohistochemical studies (Fig. enhance sodium excretion by increasing the medullary 4). DNP immunoreactivity was located in the perinuclear blood flow. The decrease in RBF observed during the region of canine atrial myocytes. recovery period, which followed a 150-minute washout, may reflect responses to intravascular volume contrac-DISCUSSION tion following natriuresis and diuresis. An additional explanation could be a similarity to the intrarenal actions This study demonstrates for the first time, to our knowledge, that DNP has potent natriuretic and diuretic of ANP, which were initially reported to be associated 132 Ϯ 8 GFR ml /min 37 Ϯ 2 4 1Ϯ 4 3 9 Ϯ 2 2 6 Ϯ 7 CNP pg /ml 9.7 Ϯ 0.5 9.1 Ϯ 0. a nonhuman mammalian species. Specifically, we report DNP-LI presence in canine plasma, urine, and atrial myocardium employing radioimmunoassay and immunohistochemical methods, which possess no cross-reacwith a transient renal vasodilation followed by renal vativity to the other known natriuretic peptides. soconstriction [4, 20] .
Further studies are clearly required specifically to We chose two different doses for DNP to establish a identify the DNP gene and to determine precise species broad range of plasma concentrations. Importantly, the amino acid sequences for DNP. Future studies emlower dose achieved circulating concentrations of approxiploying acute and chronic increases in cardiac filling presmately 250 pg/ml, which we now know are at the upper sures as well as DNP antibodies will be needed to address range of those observed in human heart failure and thus release mechanisms for endogenous DNP, as well as the may be considered pathophysiological. The higher dose physiological role of DNP in sodium homeostasis. These clearly establishes the pharmacological actions of synstudies are beyond the scope of this study, which defined, thetic DNP by achieving concentrations of approximately to our knowledge for the first time, the renal actions of 3000 pg/ml. Although the high dose represents pharmasynthetic DNP. cological actions, the observed renal responses provide In summary, we report that intravenous administrainsight into the potential therapeutic utility of DNP.
tion of synthetic DNP results in natriuresis and diuresis In a recent study, our group reported the presence of in normal dogs and that DNP-LI is present in canine DNP-LI in human plasma and atrial myocardium, with plasma, urine, and atrial myocardium. This natriuresis elevated concentrations in plasma in humans with congestive heart failure [12] . This study importantly confirms and diuresis is associated with activation of the cGMP sodium; RBF, renal blood flow; RIA, radioimmunoassay; U cGMP V, urisystem and is localized to the terminal nephron indepennary cGMP excretion; U Na V, urinary sodium excretion; UV, urine flow. dent of changes in GFR, RBF, or plasma concentrations of ANP, BNP, or CNP.
